Patient Education Sheet Library
Search Results
Nogapendekin Alfa Inbakicept and Bacillus Calmette-Guérin
The combination of nogapendekin alfa inbakicept (NAI) and bacillus calmette-guérin (BCG) is used for bladder…
Treatment Given by InjectionDownloads:
Download (English)Nadofaragene Firadenovec
Nadofaragene firadenovec is used for certain types of bladder cancer.
Treatment Given by InjectionDownloads:
Downloads:
Emicizumab
Emicizumab is used to prevent or reduce the frequency of bleeding episodes in people with…
Treatment Given by InjectionDownloads:
Cladribine, Cytarabine, and Venetoclax
The combination of cladribine, cytarabine, and venetoclax is used for acute myeloid leukemia (AML).
Treatment Given by Infusion Treatment Given by Injection Treatment Taken by MouthDownloads:
Ibrutinib and BR
The combination of ibrutinib and BR (bendamustine and rituximab) is used for chronic lymphocytic leukemia…
Treatment Given by Infusion Treatment Given by Injection Treatment Taken by MouthDownloads:
Cyclophosphamide, Bortezomib, and Dexamethasone
The combination of cyclophosphamide, bortezomib, and dexamethasone (CyBorD or VCD) is used for multiple myeloma…
Treatment Given by Infusion Treatment Given by Injection Treatment Taken by MouthDownloads:
Pembrolizumab and Paclitaxel
The combination of pembrolizumab and paclitaxel is used for breast cancer and ovarian, fallopian tube,…
Treatment Given by Infusion Treatment Given by InjectionDownloads:
Belantamab Mafodotin and Vd
The combination of belantamab mafodotin, bortezomib, and dexamethasone (BVd) is used for multiple myeloma (MM).
Treatment Given by Infusion Treatment Given by Injection Treatment Taken by MouthDownloads:
Atezolizumab and FOLFOX
The combination of atezolizumab and FOLFOX (leucovorin, fluorouracil (5-FU), and oxalilatin) is used for colon…
Treatment Given by Infusion Treatment Given by InjectionDownloads:
Popular Searches
PES Review Committee
The Patient Education Sheet (PES) Committee is a multidisciplinary team of oncology professionals who guide the development and review of these important resources. This committee ensures that every PES is accurate, clear, and meaningful for patients and caregivers navigating cancer treatment.
Led by NCODA and supported through collaboration with three leading professional organizations—ACCC, HOPA, and ONS—the committee combines expertise from across the oncology care spectrum. Together, they uphold best practices, promote consistency in patient education, and remain committed to improving outcomes through accessible, patient-centered information.
